Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 25 Issue 2, February 2024

Immune dysregulation in long COVID

Yin et al. use Olink proteomics and single‐cell RNA sequencing (scRNA-seq) analyses to show a dysregulated crosstalk between the cellular and humoral immune responses in individuals with long COVID 8 months after infection with SARS-CoV-2.

See Kailin Yin et al.

Image credit: Amie Fernandez. Cover design: Amie Fernandez

Editorial

Top of page ⤴

Research Highlights

Top of page ⤴

News & Views

  • The transcription cofactor TLE3 interacts with RUNX3 and TCF1 to repress the transcription and chromatin accessibility of CD8+ TCM cell signature genes, while simultaneously acting as a coactivator for TBET to facilitate the expression of CD8+ TEM cell signature genes. As such, TLE3 serves as a gatekeeper of CD8+ TCM cell formation.

    • Jian Shen
    • Siying Lin
    • Weiguo Cui
    News & Views
  • Anatomical separation exists between the generation and lodging sites of plasma cells. Transcriptome analysis of tissue-resident plasma cells provides important insights into how newly generated plasma cells acquire longevity.

    • Wataru Ise
    • Tomohiro Kurosaki
    News & Views
  • Apart from lifestyle, environment and chance events, genetic factors have a key role in delineating the health and longevity of an individual. Research by Park et al. has now shed light on the role of mammalian GIMAP5, a longevity-assurance (LASS) gene encoding a GTP-binding protein that regulates ceramide synthesis and cellular senescence.

    • Atrayee Gope
    • Claudio Mauro
    News & Views
Top of page ⤴

Research Briefings

  • The effectiveness of pneumococcal vaccines declines with age for unknown reasons. We studied the responses of older adults to the 23-valent PPSV23 and the 13-valent PCV13, identifying distinct baseline immune characteristics associated with vaccine responsiveness, including a cytotoxicity signature associated with weaker responses to PCV13.

    Research Briefing
  • In this proof-of-concept study, we present a next-generation poxvirus vaccine that features a ‘two-in-one’ immunogen. Our protein vaccine construct, DAM, combines the monkeypox virus antigens A35 and M1, and was produced on the basis of structure-guided design. The DAM subunit vaccine elicited superior antiviral immunity with safety compared to cocktail vaccines or a live vaccinia virus vaccine.

    Research Briefing
  • Sepsis is a global health issue in great need of effective therapies. Analysis of gene expression profiles in different tissues and at the whole-body level in mice enabled the characterization of the organism-wide host response to sepsis, which will help to build a unified mechanistic framework for the disease.

    Research Briefing
Top of page ⤴

Review Articles

  • In this Review, Wilfahrt and Delgoffe discuss how T cells integrate nutrient sensing with activating stimuli to shape their differentiation and sensitivity to metabolites.

    • Drew Wilfahrt
    • Greg M. Delgoffe
    Review Article
Top of page ⤴

Letters

Top of page ⤴

Articles

Top of page ⤴

Resources

Top of page ⤴

Amendments & Corrections

Top of page ⤴

Search

Quick links